spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Traumatic Spinal Cord Injury 

 HSMN NewsFeed - 29 Mar 2022
Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells(R) treatment for Traumatic Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 17 Sep 2013
InVivo Therapeutics Appoints Gregory D. Perry as Interim CFO
Devices Neurosurgery Personnel
 HSMN NewsFeed - 18 Dec 2012
Biogen Executive Kenneth DiPietro Joins InVivo Therapeutics Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 21 Jun 2012
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 May 2012
Former Stryker Executive Robert Housler Jr. Joins InVivo Therapeutics as Vice President of Business Development
Devices Personnel
 HSMN NewsFeed - 11 May 2012
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 22 Feb 2012
Stryker’s 2010 Innovator of the Year Brian Hess Joins InVivo Therapeutics as Director of Product Development
Devices Personnel
 HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2011
InVivo Therapeutics Promotes Lauren Mitarotondo to Vice President, Operations as InVivo Prepares for Human Studies
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Jun 2011
Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
Biopharmaceuticals
 HSMN NewsFeed - 17 Feb 2011
InVivo Therapeutics Appoints Phil Pereira Director of Manufacturing
Devices Personnel
 HSMN NewsFeed - 10 Feb 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology
 HSMN NewsFeed - 9 Feb 2011
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Regenerative Medicine
 HSMN NewsFeed - 21 Jan 2010
Neuralstem Announces First Patient Treated in ALS Stem Cell Trial
Regenerative Medicine Neurology
 HSMN NewsFeed - 21 Sep 2009
Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 20 Feb 2009
Neuralstem's ALS Trial on Clinical Hold
Regenerative Medicine Neurology
 HSMN NewsFeed - 14 Oct 2008
Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
Devices Drug Delivery Regenerative Medicine Neurology
 HSMN NewsFeed - 18 Sep 2008
The European Commission Grants Orphan Drug Designation to Alseres Pharmaceuticals' Spinal Cord Injury Treatment, Cethrin(R)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 12 May 2008
Neuralstem Responds to New StemCells, Inc. Lawsuit
Regenerative Medicine Litigation
 HSMN NewsFeed - 7 May 2008
Neuralstem Sues StemCells, Inc. Over New Patent
Regenerative Medicine Neurology Litigation
 HSMN NewsFeed - 6 May 2008
Neuralstem Goes to Court for Summary Judgment Against StemCells, Inc.
Regenerative Medicine Neurology Litigation
 HSMN NewsFeed - 15 Apr 2008
Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
Regenerative Medicine Litigation
 HSMN NewsFeed - 20 Feb 2008
Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
Regenerative Medicine Licensing
 HSMN NewsFeed - 20 Nov 2007
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
Regenerative Medicine Neurology Licensing
 HSMN NewsFeed - 19 Sep 2007
Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc.
Regenerative Medicine Neurology Litigation
 HSMN NewsFeed - 19 Jun 2007
Nobel Prize Winning Scientist Joins InVivo Therapeutics Team
Devices Personnel
 HSMN NewsFeed - 30 May 2007
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
Regenerative Medicine
 HSMN NewsFeed - 24 Apr 2007
William C. Oldaker and Scott V. Ogilvie Join Neuralstem Board of Directors
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 10 Apr 2007
John Conron Joins Neuralstem as Chief Financial Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 16 Mar 2007
Neuralstem Inc. Raises $5 Million in a Private Placement
Regenerative Medicine Neurology
 HSMN NewsFeed - 11 Jan 2007
Neuralstem Licenses Out Compounds for Diabetes Treatment
Regenerative Medicine Licensing
 HSMN NewsFeed - 6 Apr 2006
New Data Show Cialis(R) (tadalafil) is Effective in Treating Erectile Dysfunction Caused by Traumatic Spinal Cord Injury
Biopharmaceuticals Urology
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.